Ceftriaxone sodium salt CAS:104376-79-6
Ceftriaxone sodium salt is prescribed by healthcare providers for the treatment of infections such as pneumonia, meningitis, urinary tract infections, septicemia, gonorrhea, and Lyme disease. The dosage, frequency of administration, and duration of treatment with ceftriaxone sodium salt are determined based on the type and severity of the infection, as well as individual patient factors. Patients typically receive ceftriaxone sodium salt via intravenous or intramuscular injection under medical supervision to ensure accurate dosing and monitoring of treatment response. It is crucial to adhere to the prescribed treatment regimen and complete the full course of therapy to effectively clear the infection and minimize the risk of antibiotic resistance. While generally well-tolerated, common side effects of ceftriaxone sodium salt may include gastrointestinal disturbances, allergic reactions, or injection site reactions. Patients should be monitored for any adverse reactions during treatment, and any severe or persistent side effects should be reported to a healthcare provider promptly for evaluation and appropriate management. Ceftriaxone sodium salt serves as an essential antibiotic option in clinical practice for combating bacterial infections when used appropriately under medical guidance.
Composition | C18H21N8NaO8S3 |
Assay | 99% |
Appearance | white powder |
CAS No. | 104376-79-6 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |